The Pharmacy Times® Diabetes Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of chronic diseases that result in high blood glucose.
November 21st 2024
Investigators also established a negative association with higher vitamin C intake and diabetes prevalence.
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
The Utilization of SGLT2 Inhibitors in the Treatment of Cardiovascular Disease, Diabetes, and Chronic Kidney D...
1.5 Credits / Cardiology; Endocrinology, Diabetes & Metabolism; Nephrology
View More
Integrated Continuous Glucose Monitoring Implementation and Connectivity: Best Practices, Featuring a Powered ...
1.5 Credit / Endocrinology, Diabetes & Metabolism
View More
Integrated Continuous Glucose Monitoring Implementation and Connectivity: Best Practices, Featuring a Powered ...
1.5 Credit / Endocrinology, Diabetes & Metabolism
View More
Reducing Barriers in Integrated Continuous Glucose Monitoring Use, Featuring Patient Counseling Video Vignette...
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Reducing Barriers in Integrated Continuous Glucose Monitoring Use, Featuring Patient Counseling Video Vignette...
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Integrated Continuous Glucose Monitoring: What’s New in 2024, Featuring a Device Demonstration and Patient Cou...
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Integrated Continuous Glucose Monitoring: What’s New in 2024, Featuring a Device Demonstration and Patient Cou...
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Strategies for Addressing Cardiovascular Disease, Diabetes, and Chronic Kidney Disease With SGLT2 Inhibitors
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Reducing Endocrinopathies of Immune Checkpoint Inhibitor Therapy: Management Strategies for Oncology Pharmacis...
1.0 Credit / Oncology, Endocrinology, Diabetes & Metabolism
View More
Foundations in Continuous Glucose Monitoring
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
SimulatED: Using Continuous Glucose Monitoring Data to Improve Health Outcomes
0.75 Credit / Endocrinology, Diabetes & Metabolism
View More
SimulatED: Using Continuous Glucose Monitoring Data to Improve Health Outcomes (Pharmacy Technician Credit)
0.75 Credit / Endocrinology, Diabetes & Metabolism
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Uncovering the Challenges in Treatment Pathways in AMD and DME
1.0 Credit / Endocrinology, Diabetes & Metabolism, Ophthalmology & Optometry
View More
Navigating Anti-Vascular Endothelial Growth Factor Therapy and Dosing Strategies
1.0 Credit / Endocrinology, Diabetes & Metabolism, Ophthalmology & Optometry
View More
Improving Patient Outcomes in AMD and DME Through the Integration of Specialty Pharmacy Care
1.0 Credit / Endocrinology, Diabetes & Metabolism, Ophthalmology & Optometry
View More
Best Practices for the Integration of Continuous Glucose Monitoring Within the Health System
1.5 Credits / Endocrinology, Diabetes & Metabolism
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Best Practices for the Integration of Continuous Glucose Monitoring Devices Across Community Pharmacy Settings
1.5 Credits / Endocrinology, Diabetes & Metabolism
View More
The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outc...
1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry
View More
Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support I...
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support I...
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
City of Houston and Novo Nordisk partner to lead fight against urban diabetes epidemic
November 3rd 2014The City of Houston and Novo Nordisk today announced an innovative partnership to fight the urban diabetes epidemic. Houston is the third city globally and the first in the United States to join the Cities Changing Diabetes programme, which was initiated earlier in 2014 by Novo Nordisk. The first two cities are Mexico City and Copenhagen.
Read More
New Draft Guidelines for Impaired Glucose Tolerance Screening
October 26th 2014Draft guidance by the United States Preventive Services Task Force advocates screening patients with certain risk factors for impaired glucose tolerance to delay or prevent the onset of, and long-term damage due to, T2DM.
Read More